Arrowhead Pharmaceuticals, Inc. (ARWR) Insider Ownership

Historic Insider Ownership Trends

Arrowhead Pharmaceuticals's three largest insider shareholders as of May 04, 2026 are Christopher Richard Anzalone (Chief Executive Officer, 3.79Mn shares), Christopher Richard Anzalone (Chief Executive Officer, 3.79Mn shares), Patrick O'Brien (Coo, 547.41K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Christopher Richard Anzalone Chief Executive Officer 3,792,739 0 05 Jan, 2026
Christopher Richard Anzalone Chief Executive Officer 3,792,739 0 05 Jan, 2026
Patrick O'Brien Coo 547,408 0 08 Jan, 2026
Patrick O'Brien Coo 547,408 0 08 Jan, 2026
Kenneth Allen Myszkowski Chief Financial Officer 455,433 0 07 Jan, 2025
Kenneth Allen Myszkowski Chief Financial Officer 455,433 0 07 Jan, 2025
James C Hamilton Chief Medical Officer 226,958 0 24 Apr, 2026
Martin Javier San Chief Medical Officer 198,497 0 05 Jan, 2024
Daniel Joseph Apel Chief Financial Officer 162,905 0 24 Apr, 2026
Tracie Oliver Chief Commercial Officer 127,107 0 03 Jul, 2024
Tracie Oliver Chief Commercial Officer 127,107 0 03 Jul, 2024
Douglas B Given - 124,167 0 18 Dec, 2024
Michael S Perry - 123,059 0 18 Dec, 2025
Martin Javier San Chief Medical Officer 91,500 0 22 Nov, 2022
Mauro Ferrari - 69,053 0 30 Dec, 2025
Mauro Ferrari - 69,053 0 30 Dec, 2025
William D. Waddill - 56,563 0 23 Dec, 2025
William D. Waddill - 56,563 0 23 Dec, 2025
Hongbo Lu - 54,982 0 18 Dec, 2025
Douglas S Ingram - 46,215 0 18 Dec, 2025
Victoria Vakiener - 35,723 0 23 Dec, 2025
Victoria Vakiener - 35,723 0 23 Dec, 2025
Adeoye Y Olukotun - 33,600 0 23 Dec, 2025
Backer Marianne De - 31,267 0 11 Jan, 2023
Douglas B Given - 0 13,000 01 Mar, 2023

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
22 Apr, 2026 Daniel Joseph Apel Common Stock D 3,208 $70.11 172,792 D S
23 Apr, 2026 James C Hamilton Common Stock D 10,000 $75.00 226,958 D S
23 Apr, 2026 James C Hamilton Common Stock D 10,000 $75.00 226,958 D S
22 Apr, 2026 Daniel Joseph Apel Common Stock D 3,208 $70.11 172,792 D S
22 Apr, 2026 Daniel Joseph Apel Common Stock D 3,208 $70.11 172,792 D S
22 Apr, 2026 Daniel Joseph Apel Common Stock D 3,208 $70.11 172,792 D S
23 Apr, 2026 James C Hamilton Common Stock D 10,000 $75.00 226,958 D S
22 Apr, 2026 Daniel Joseph Apel Common Stock D 3,208 $70.11 172,792 D S
23 Apr, 2026 James C Hamilton Common Stock D 10,000 $75.00 226,958 D S
23 Apr, 2026 James C Hamilton Common Stock D 10,000 $75.00 226,958 D S
22 Apr, 2026 Daniel Joseph Apel Common Stock D 1,157 $70.45 171,635 D S
22 Apr, 2026 Daniel Joseph Apel Common Stock D 1,157 $70.45 171,635 D S
22 Apr, 2026 Daniel Joseph Apel Common Stock D 1,157 $70.45 171,635 D S
22 Apr, 2026 Daniel Joseph Apel Common Stock D 1,157 $70.45 171,635 D S
22 Apr, 2026 Daniel Joseph Apel Common Stock D 1,157 $70.45 171,635 D S
22 Apr, 2026 Daniel Joseph Apel Common Stock D 8,730 $71.92 162,905 D S
22 Apr, 2026 Daniel Joseph Apel Common Stock D 8,730 $71.92 162,905 D S
22 Apr, 2026 Daniel Joseph Apel Common Stock D 8,730 $71.92 162,905 D S
22 Apr, 2026 Daniel Joseph Apel Common Stock D 8,730 $71.92 162,905 D S
22 Apr, 2026 Daniel Joseph Apel Common Stock D 8,730 $71.92 162,905 D S